Remove Health Care Remove Innovation Remove Marketing Remove Venture Capitalist
article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? “Why bother?”.

article thumbnail

Alphabet Isn’t a Typical Conglomerate

Harvard Business Review

Its creation marks the beginning of the end of the e-commerce era defined by browsers, search, maps, and apps and monetized through advertising and the beginning of the next arc of digital transformation of industries (automotive, health care, and others) propelled by the combination of human minds and powerful machines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Big Companies Can Unleash Innovation, Rather than Shackle It

Harvard Business Review

In today's world, start-ups aren't the only ones who can innovate. As I discussed in my post How Big Companies Can Save Innovation , large companies are now better positioned to innovate than ever before. Innovation increasingly involves creating business models that tap big companies' unique strengths.

article thumbnail

The $300 House: The Marketing Challenge

Harvard Business Review

Today, Seth Godin examines the challenge of marketing to the world's poor. That's enough to participate in other productivity or life-enhancing investments, like a well, or a roof, or health care. Its success will depend on the ability to create a market for the idea. Acumen creates these markets using patient capital.

article thumbnail

For Some Platforms, Network Effects Are No Match for Local Know-How

Harvard Business Review

Uber’s setback in the international market, however, wasn’t its first. To venture capitalists and the financial market, no business model is more attractive than a platform. Any platform still needs to achieve a product-market fit to succeed in the long run.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Change and innovation are choices, not givens, in any organization, and there are managerial levers for making these selections wisely. Within EB, Merck first created a Global Health Innovation Fund and then a Healthcare Services and Solution unit to identify, develop, and operate nascent opportunities that fit that thesis.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. Have all the innovative ideas already been done? What gives?